These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines. Wysocki J, Tejedor JC, Grunert D, Konior R, Garcia-Sicilia J, Knuf M, Bernard L, Dieussaert I, Schuerman L. Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S77-88. PubMed ID: 19325450 [Abstract] [Full Text] [Related]
4. Induction of immunologic memory following primary vaccination with the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine in infants. Knuf M, Pankow-Culot H, Grunert D, Rapp M, Panzer F, Köllges R, Fanic A, Habib A, Borys D, Dieussaert I, Schuerman L. Pediatr Infect Dis J; 2012 Jan; 31(1):e31-6. PubMed ID: 21909049 [Abstract] [Full Text] [Related]
5. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine. Vesikari T, Wysocki J, Chevallier B, Karvonen A, Czajka H, Arsène JP, Lommel P, Dieussaert I, Schuerman L. Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S66-76. PubMed ID: 19325449 [Abstract] [Full Text] [Related]
6. Tolerability and immunogenicity of an eleven valent mixed carrier Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid or tetanus protein conjugate vaccine in Finnish and Israeli infants. Dagan R, Kayhty H, Wuorimaa T, Yaich M, Bailleux F, Zamir O, Eskola J. Pediatr Infect Dis J; 2004 Feb; 23(2):91-8. PubMed ID: 14872172 [Abstract] [Full Text] [Related]
7. Avidity and subclasses of IgG after immunization of infants with an 11-valent pneumococcal conjugate vaccine with or without aluminum adjuvant. Wuorimaa T, Dagan R, Väkeväinen M, Bailleux F, Haikala R, Yaich M, Eskola J, Käyhty H. J Infect Dis; 2001 Nov 01; 184(9):1211-5. PubMed ID: 11598848 [Abstract] [Full Text] [Related]
8. Greater antibody responses to an eleven valent mixed carrier diphtheria- or tetanus-conjugated pneumococcal vaccine in Filipino than in Finnish or Israeli infants. Puumalainen T, Dagan R, Wuorimaa T, Zeta-Capeding R, Lucero M, Ollgren J, Käyhty H, Nohynek H. Pediatr Infect Dis J; 2003 Feb 01; 22(2):141-9. PubMed ID: 12586978 [Abstract] [Full Text] [Related]
18. Immunogenicity and boosting after a reduced number of doses of a pneumococcal conjugate vaccine in infants and toddlers. Goldblatt D, Southern J, Ashton L, Richmond P, Burbidge P, Tasevska J, Crowley-Luke A, Andrews N, Morris R, Borrow R, Cartwright K, Miller E. Pediatr Infect Dis J; 2006 Apr 01; 25(4):312-9. PubMed ID: 16567982 [Abstract] [Full Text] [Related]
19. IgG antibody concentrations after immunization with 11-valent mixed-carrier pneumococcal conjugate vaccine in efficacy trial against pneumonia among Filipino infants. Soininen A, Nohynek H, Lucero M, Jousimies K, Ugpo J, Williams G, Käyhty H, ARIVAC Consortium. Vaccine; 2009 May 05; 27(20):2680-8. PubMed ID: 19428879 [Abstract] [Full Text] [Related]
20. Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV). Knuf M, Szenborn L, Moro M, Petit C, Bermal N, Bernard L, Dieussaert I, Schuerman L. Pediatr Infect Dis J; 2009 Apr 05; 28(4 Suppl):S97-S108. PubMed ID: 19325452 [Abstract] [Full Text] [Related] Page: [Next] [New Search]